HAPP - Happiness Biotech Group Limited: The Losing Streak Continues (HAPP)
Shares of Happiness Biotech Group Limited (NASDAQ:HAPP) traded at a new 52-week low today of $1.59. Approximately 242,000 shares have changed hands today, as compared to an average 30-day volume of 209,000 shares.
There is potential upside of 167.2% for shares of Happiness Biotech Group Limited based on a current price of $1.60 and an average consensus analyst price target of $4.28.
In the past 52 weeks, shares of Happiness Biotech Group Limited have traded between the current low of $1.59 and a high of $3.25 and is now at $1.60.
Happiness Biotech Group Ltd is a nutraceutical and dietary supplements producer focused on the research, development, manufacturing, and marketing of products made from Chinese herbal extracts. Its products include Lucidum spore powder products, Cordyceps mycelia products, Ejiao solution products, Vitamins, and dietary supplements products, American ginseng products, and others. The company generates maximum revenue from Lucidum spore powder products.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer